The Cost-Effectiveness Of Novel Oral Anticoagulants For The Prevention Of Stroke In Atrial Fibrillation In England And Wales

Determine the most cost-effective, licensed, first-line anticoagulant for the prevention of ischemic stroke in patients with non-valvular atrial fibrillation (AF) in England and Wales from the perspective of the UK National Health Service.

Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: H Thom, W Hollingworth, PA Bryden, J Sterne, PN Bodalia, P Davies, JA Lopez-Lopez, GN Okoli, DM Caldwell, S Dias, D Eaton, J Higgins, C Salisbury, J Savovic, R Sofat, A Stephens-Boal, A Hingorani, NJ Welton Source Type: research